Zai Lab Limited
ZLABNASDAQHealthcare● Active
$16.60
$-0.02(-0.12%)
Market Cap$1.9B
P/E Ratio—
52W High$44.34
52W Low$15.96
Zai Lab Limited (ZLAB) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ZLAB · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
-$0.46
Est. -$0.53 · +12.6%
Revenue
$0.10B
Est. $0.11B · -8.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 1-Quarter EPS Beat Streak
ZLAB reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | -$0.67 | — | — | — | $0.10B | — |
| ▲ Q2 FY2026 | May 7, 2026 | -$0.53 | -$0.46 | +12.6% | $0.10B | $0.11B | -8.1% |
| ▼ Q1 FY2026 | Feb 26, 2026 | -$0.44 | -$0.46 | -4.5% | $0.13B | $0.12B | +4.5% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -$0.28 | -$0.33 | -17.9% | $0.12B | $0.13B | -8.4% |
| — Q3 FY2025 | Aug 7, 2025 | -$0.37 | -$0.37 | +0.0% | $0.11B | $0.15B | -26.8% |
| ▲ Q2 FY2025 | May 8, 2025 | -$0.50 | -$0.45 | +10.0% | $0.11B | $0.13B | -16.5% |
| ▼ Q1 FY2025 | Feb 27, 2025 | -$0.61 | -$0.80 | -31.1% | $0.11B | $0.11B | -1.0% |
| ▲ Q4 FY2024 | Nov 12, 2024 | -$0.75 | -$0.42 | +44.0% | $0.10B | $0.11B | -6.1% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
-$0.67
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
-$0.46
EPS Est.
-$0.53
EPS Surpr.
+12.6%
Revenue
$0.10B
Q1 FY2026
Feb 26, 2026Miss
EPS Actual
-$0.46
EPS Est.
-$0.44
EPS Surpr.
-4.5%
Revenue
$0.13B
Q4 FY2025
Nov 6, 2025Miss
EPS Actual
-$0.33
EPS Est.
-$0.28
EPS Surpr.
-17.9%
Revenue
$0.12B
Q3 FY2025
Aug 7, 2025
EPS Actual
-$0.37
EPS Est.
-$0.37
EPS Surpr.
+0.0%
Revenue
$0.11B
Q2 FY2025
May 8, 2025Beat
EPS Actual
-$0.45
EPS Est.
-$0.50
EPS Surpr.
+10.0%
Revenue
$0.11B
Q1 FY2025
Feb 27, 2025Miss
EPS Actual
-$0.80
EPS Est.
-$0.61
EPS Surpr.
-31.1%
Revenue
$0.11B
Q4 FY2024
Nov 12, 2024Beat
EPS Actual
-$0.42
EPS Est.
-$0.75
EPS Surpr.
+44.0%
Revenue
$0.10B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.38 | $-0.35 | $-0.33 | 1 |
| Q3 FY2027 | $-0.45 | $-0.41 | $-0.38 | 1 |
| Q2 FY2027 | $-0.49 | $-0.45 | $-0.42 | 1 |
| Q1 FY2027 | $-0.54 | $-0.49 | $-0.46 | 1 |
| Q4 FY2026 | $-0.58 | $-0.53 | $-0.49 | 1 |
| Q3 FY2026 | $-0.58 | $-0.53 | $-0.49 | 3 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.2B | $0.2B | $0.2B | 3 |
| Q3 FY2027 | $0.1B | $0.2B | $0.2B | 2 |
| Q2 FY2027 | $0.1B | $0.1B | $0.2B | 2 |
| Q1 FY2027 | $0.1B | $0.1B | $0.1B | 3 |
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 3 |
| Q3 FY2026 | $0.1B | $0.1B | $0.1B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +12.6% | $21.01 | $19.77 | -5.90% |
| ▼ Q1 FY2026 | Feb 26, 2026 | -4.5% | $19.39 | $19.69 | +1.55% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -17.9% | $24.80 | $23.15 | -6.65% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +0.0% | $38.72 | $34.08 | -11.98% |
| ▲ Q2 FY2025 | May 8, 2025 | +10.0% | $28.36 | $29.14 | +2.75% |
| ▼ Q1 FY2025 | Feb 27, 2025 | -31.1% | $35.07 | $34.38 | -1.97% |
| ▲ Q4 FY2024 | Nov 12, 2024 | +44.0% | $31.09 | $28.96 | -6.85% |
| ▼ Q3 FY2024 | Aug 6, 2024 | -24.2% | $17.64 | $18.11 | +2.66% |
Q2 FY2026-5.90%
Report Date
May 7, 2026
EPS Beat/Miss
+12.6%
Price Before
$21.01
Price After
$19.77
Q1 FY2026+1.55%
Report Date
Feb 26, 2026
EPS Beat/Miss
-4.5%
Price Before
$19.39
Price After
$19.69
Q4 FY2025-6.65%
Report Date
Nov 6, 2025
EPS Beat/Miss
-17.9%
Price Before
$24.80
Price After
$23.15
Q3 FY2025-11.98%
Report Date
Aug 7, 2025
EPS Beat/Miss
+0.0%
Price Before
$38.72
Price After
$34.08
Q2 FY2025+2.75%
Report Date
May 8, 2025
EPS Beat/Miss
+10.0%
Price Before
$28.36
Price After
$29.14
Q1 FY2025-1.97%
Report Date
Feb 27, 2025
EPS Beat/Miss
-31.1%
Price Before
$35.07
Price After
$34.38
Q4 FY2024-6.85%
Report Date
Nov 12, 2024
EPS Beat/Miss
+44.0%
Price Before
$31.09
Price After
$28.96
Q3 FY2024+2.66%
Report Date
Aug 6, 2024
EPS Beat/Miss
-24.2%
Price Before
$17.64
Price After
$18.11
Avg Beat Reaction-5.50%
Avg Miss Reaction-1.10%
Beat Rate4 / 8 quarters
Largest Move-11.98% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ZLAB ends December
Zai Lab Limited (ZLAB) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $-0.46 — beating the analyst consensus of $-0.53 by +12.6%. The next ZLAB earnings date is expected around September 1, 2026.
Each quarter, investors track ZLAB earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ZLAB revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ZLAB's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ZLAB earnings · 5 questionsZai Lab Limited's next earnings report is expected around September 1, 2026. ZLAB typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ZLAB historically reports after market close (AMC).
ZLAB earnings datewhen is ZLAB earningsZLAB next earnings datewhen does ZLAB report earningsZLAB earnings calendar
▸ Source: FMP · Zai Lab Limited SEC filings · US GAAP · Zai Lab Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026